Exane Asset Management’s Incyte INCY Stock Holding History

Exane Asset Management’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,000	Closed	-$126K	–	132
2017 Q2	$126K	Buy	+1,000	New	+$127K	0.04%	57

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Exane Asset Management's INCY Position: Q3 2017 in Review

Exane Asset Management sold out of Incyte (INCY) in Q3 2017, closing a stake of 1,000 shares — an estimated $126K sold.

Exane Asset Management first reported a position in INCY in Q2 2017 and held it in 1 quarter. The position peaked at $126K in Q2 2017. 496 funds tracked by Wall St. Rank hold INCY as of Q3 2017.

Exane Asset Management reported no remaining Incyte position as of Q3 2017 after selling out during the quarter.
Exane Asset Management sold 1,000 Incyte shares in Q3 2017, an estimated $126K.
Exane Asset Management first reported a position in Incyte in Q2 2017 and held it in 1 quarter.
Exane Asset Management's Incyte position peaked at $126K in Q2 2017.
496 funds tracked by Wall St. Rank held Incyte as of Q3 2017.

Based on Exane Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.